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http://dx.doi.org/10.1016/j.pedneo.2
1875-9572/Copyright ª 2013, Taiwan
CC BY-NC-ND license (http://creativDeep vein thrombosis (DVT) is a rare disease in pediatric patients. We report a pediatric pa-
tient who developed DVT in association with methicillin-resistant Staphylococcus aureus
(MRSA) bacteremia complicated with septic arthritis, osteomyelitis, and myositis extensively.
It is crucial to consider musculoskeletal infection associated with DVT in any child who pre-
sents with severe swollen limbs and limitations of motion. Prompt antibiotic and anticoagulant
treatments should be initiated to reduce the risk of fatal complications.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Deep vein thrombosis (DVT) is a relatively rare disease in
pediatric patients.1,2 According to previous studies, venous
thromboembolic disease has an annual incidence of 1 perof Pediatrics, Taipei Veter-
ih-Pai Road, Section 2, Taipei
tw (Y.-S. Lee).
013.09.004
Pediatric Association. Published
ecommons.org/licenses/by-nc-nd100,000 and 0.74 per 100,000 in Singapore and Hong Kong
Chinese children (< 15 years of age), respectively.3,4 The
most important risk factor for DVT in children is the pres-
ence of a central venous line. In addition to infection,
trauma and congenital heart disease are also common risk
factors. The Virchow triad, including venous stasis, endo-
thelial damage, and a hypercoagulation state, is the path-
ophysiology in venous thromboembolic disease. Outcomes
of DVT in children may differ depending on anatomic sites,
hemorrhage, superior vena cava syndrome, renal insuffi-
ciency, limb gangrene, and recurrent DVT. Herein, we
report a pediatric patient with exceptionally extensiveby Elsevier Taiwan LLC. This is an open access article under the
/4.0/).
Septic thrombosis in a child 245regional septic arthritis, osteomyelitis, and myositis
complicated with septic DVT secondary to community-
associated methicillin-resistant Staphylococcus aureus
(CA-MRSA). After a complete course of antibiotics plus
anticoagulation treatments, without surgical intervention,
this patient recovered fully. No complications were noted
during the following 2 years.2. Case Report
A previously healthy 23-month-old boy with an initial pre-
sentation of intermittent high fever up to 39.5 C for 3 days
was sent to the emergency room (ER) of our hospital. Ac-
cording to the statement of the patient’s mother, he had
suffered fromamild cough, decreased activity, poor appetite
accompanied with vomiting, and right lower extremity pain
that had been ongoing for approximately 2 days. The patient
had no known history of major trauma prior to this episode.
Physical examination at the ER revealed a mildly injected
throat andbilateral coarsebreathing sounds. Thewhite blood
cell countwas29,500/CUMMwithabandof 1%and segmentof
84%. The level of C-reactive protein (CRP) was 35.7 mg/L
(normal 0e5mg/L). The urine analysis results were negative.
A chest radiograph showed mild bilateral infiltration. The
patient was then admitted to theward under the suspicion of
a lower respiratory tract infection.
Pain and swelling over the right hip with weakness of the
right lower extremity were noted on the 3rd day after
admission. A physical examination showed local heat,
tenderness, and erythematous changes over the right hip
joint and inguinal area, accompanied by right lower ex-
tremity swelling and edema. The range of motion of the
patient’s right lower extremity was limited. Doppler ultra-
sonography of the limbs showed DVT of the right femoral
vein. Laboratory examinations revealed: D-dimer 6.62 ug/
mL (normal < 0.55 mg/mL), fibrinogen 527 mg/dL (normal
200e400 mg/dL), fibrin degradation products 16.54 mg/mL
(normal < 5 mg/mL). The osteomyelitis scan showed an
increased signal over the right hip region (Figure 1). A
magnetic resonance imaging (MRI) study of the lower ex-
tremities revealed thrombophlebitis of the right femoral
vein, septic arthritis over the right hip joint, osteomyelitisFigure 1 Osteomyelitis scan: increased blood pool and Gover the right femoral bone, and myositis (Figure 2A and B).
The coagulation profile and immunity tests from this pa-
tient all showed no abnormal findings: a protein C func-
tional assay of 63% and a protein S functional assay of 161%.
Antibiotic treatmentwith Unasyn (ampicillinþ sulfactum,
25 mg ampicillin/kg/dose, q6h) was given after hospital
admission. A blood culture revealedMRSA on the 3rd day after
admission. MRSA was sensitive to gentamycin, vancomycin,
linezolid, trimethoprim/sulfamethoxazole and resistant to
oxacillin, ampicillin, clindamycin, penicillin-G, ceftriaxone,
tetracycline, and cefazolin. Antibiotic treatment was there-
fore shifted to vancomycin (10 mg/kg/dose, q6h) because of
diffuse soft tissue infection and bacteremia. Owing to the rise
in CRP to 14.7 mg/dL and intermittent fever that persisted
after 4 days of vancomycin treatment, the antibiotic regimen
was switched to daptomycin (10 mg/kg/dose, qd), according
to the recommendation of a pediatric infectious disease
specialist because of poor clinical response and elevated
laboratory parameters. A pediatric orthopedist was also
consulted and he suggested no indication of surgical inter-
vention due to the fact that no motion limitations were
observed clinically and no pus formation was observed ac-
cording to the image. Antibiotic treatment with daptomycin
was provided for 6 weeks and follow-up blood culture showed
no bacteria growth.
After DVT was diagnosed by Doppler ultrasonography of
the limbs, low molecular weight heparin (LMWH) was
administered for 2 weeks, and then shifted to the oral form
antithrombotic agent, warfarin. Warfarin was given for
nearly 5.5 months and the dosage was adjusted to keep the
International Normalized Ratio (INR) at approximately
2e2.5. The total duration of the anticoagulant therapy,
including LMWH and warfarin, was 6 months.
An MRI study was performed 1 month later after antibi-
otic and anticoagulant treatment, and it showed a regres-
sive change. Recanalization of the femoral vein was noted
on the Doppler ultrasonography of the limbs after 40 days of
treatment. The Doppler ultrasonography of the limbs was
followed 3 months later after completion of warfarin
treatment, and it showed partial residual thrombosis of the
right femoral vein.
This patient experienced no major complications during
the entire course of antibiotic and anticoagulant treatment.a-67 in the right hip region, compatible with cellulitis.
Figure 2 Magnetic resonance imaging showed (A) deep vein
thrombosis (DVT): thrombosis of the right femoral vein, suggestive
of thrombophlebitis and (B) septic arthritis, osteomyelitis, and
myositis: thickening and contrast enhancement in the synovial in
the right hip joint, bone marrow enhancement in the metaphysic
and extending to the proximal third of diaphysis, swelling, and
increasedenhancement in themuscles (including glutealmuscles,
vastus muscles, and part of the adductor muscles) and fascia.
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tient clinic showed normal strength and range of motion in
the child’s joints.
3. Discussion
Venous thromboembolism is a rare disorder in children. The
National Hospital Discharge Survey reported that theincidence rate in the USA was 0.49 per 10,000 per year.
Epidemiological data have also revealed that the age dis-
tribution of this condition is bimodal, especially in the
neonatal and adolescent period.5,6 Venous thrombosis with
osteomyelitis occurs rarely, but may be life-threatening.7,8
The pathogenesis of venous thromboembolism consists
of venous stasis, endothelial damage, and the hyper-
coagulation state, which is called the Virchow triad.9,10 The
most important predisposing factor for DVT is implantation
of a central venous catheter.11 The previous literature re-
ported that approximately 89% of venous thromboembolism
cases in newborns are associated with an intravascular
catheter.12 In addition, infection and trauma are also the
etiologies of endothelial damage, especially minimal
trauma as a risk factor for septic thrombosis in children.10
CA-MRSA is the most common pathogen involved in venous
thrombosis with osteomyelitis.7,13e15 In our case, there was
no central venous catheter implantation. However, infec-
tion of local soft tissue was diagnosed and blood culture
revealed MRSA, which are consistent with previous reports.
We observed that diffuse soft tissue infection as septic
arthritis, osteomyelitis, and myositis can be associated with
DVT in children.
According to the study of Huang and Chen,16 CA-MRSA
infections have been increasingly reported in pediatric
patients since 2000 in Taiwan and the isolation rate from
pediatric CA-S. aureus infections has recently been more
than 50%. Skin and soft-tissue infection was the most
common presentation of CA-MRSA infection in Taiwanese
children and accounted for 83% of all reported cases. CA-
MRSA clinical isolates were also resistant to multiple anti-
biotics, including clindamycin (> 90%), erythromycin (>
90%), and chloramphenicol (57e65%), but were less resis-
tant to gentamicin (21e34%). All CA-MRSA isolates were
susceptible to vancomycin and teicoplanin and > 90% were
susceptible to ciprofloxacin, fusidic acid, minocycline, and
rifampicin. The majority of CA-MRSA isolates in Taiwan
belonged to the sequence type (ST) 59 lineage, defined by
multilocus sequence typing, and the most common molec-
ular characteristics of CA-MRSA clinical isolates were ST59/
pulsed-field gel electrophoresis type D/staphylococcal
chromosomal cassette mec VT/PantoneValentine leukoci-
din (PVL)-positivity.16
Vascular complications, such as DVT, were more com-
mon and more severe in patients with MRSA musculoskel-
etal infections compared with methicillin-sensitive S.
aureus infections, especially for those with pulmonary
involvement. MRSA infections also presented with signifi-
cantly higher inflammatory markers and increased lengths
of hospital stays. A number of factors may predispose to the
development of DVT in osteomyelitis caused by S. aureus.
Bacterial adhesion to thrombogenic surfaces plays an
important pathogenic role. S. aureus release various exo-
toxins, which act on cell membranes and produce aggre-
gation of platelets and smooth muscle spasm, both of which
predispose to thrombosis, whereas the enzyme coagulase
interacts with fibrinogen and causes plasma clotting. Be-
sides, leukocidin, a multicomponent protein toxin and the
product of the PVL gene, may also be the responsible toxin
associated with DVT.14 The molecular characteristic in CA-
MRSA may be associated with the disease spectrum,
severity, and prognosis. Although our patient did not
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further investigation to explore the molecular characteris-
tics in CA-MRSA infection may provide valuable information
in clinical practice.
The clinical presentations of fever with unilateral pain
and swelling are often noted in DVT patients,8,13 but the
condition can also be asymptomatic. The femoral and
popliteal veins are most commonly affected,7,13 and our
patient suffered from right femoral vein involvement. The
predominance of DVT in males has been noted,7,13,14 and
our case supported this tendency.
The Doppler ultrasonography is the most common
applicable diagnostic tool among DVT patients. However,
magnetic resonance angiography or computed tomography
is needed in some cases, especially when thrombosis ex-
tends to the visceral vessels. The laboratory examinations
of CRP, erythrocyte sedimentation, and D-dimer revealed
elevated levels.7,15 A coagulation profile should be evalu-
ated, because protein C deficiency is a risk for venous
thromboembolism in children.2 The results of the current
patient’s coagulation profile all showed negative findings.
The treatment of musculoskeletal sepsis associated with
DVT is composed of antibiotic and anticoagulation treat-
ment. Vancomycin is the first choice of antibiotic treatment
for treating MRSA, and its dose should be adjusted
depending on a patient’s blood culture results. Daptomycin
may be effective against Gram-positive pathogens in bone
and joint infections or bacteremia in a pediatric patient,
when first-line treatment has failed. Anticoagulation
treatment was performed, comprising LMWH followed with
either LMWH or warfarin. The suggested length of treat-
ment is reported to be 2.5e10 months,7,8 (at least 3 months
is recommended).17 Warfarin treatment should be adjusted
to keep the INR between 2.0 and 3.0. The current patient
underwent anticoagulation therapy with LMWH followed by
oral warfarin for 6 months. This regimen was consistent
with previous recommendations. Inferior vena cava filters
may play a role in treatment of DVT under some clinical
conditions.17,18 Thrombolytic agents are reserved for limb
salvage or hemodynamically unstable cases.17 Surgical
therapy for DVT may be indicated when anticoagulation
therapy is ineffective or contraindicated.8 However, our
patient did not receive this invasive procedure.
Some previous reports in the literature revealed com-
plications of septic pulmonary emboli.7,8,13e15 Dyspnea,
hemoptysis, and pleuritic chest pain are common symp-
toms, with signs of crepitations, tachycardia, and
cyanosis.17 The incidence of pulmonary complications is
low, but the mortality rates can be high.8,11,17 The venti-
lation/perfusion scan is a recommended test for the pos-
sibility of pulmonary emboli in children.10,17
In conclusion, DVT is uncommon in pediatric patients, but
it should be considered in children with musculoskeletal in-
fections accompanied with swollen extremities and motion
limitations. Minor trauma is a potential risk factor for the
disease. Early recognition and prompt treatment comprising
antibiotic and anticoagulant therapy should be initiated assoon as DVT is suspected; and a delay in diagnosis may
contribute to serious sequelae and even fatal consequences.References
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